The FDA's approval of the first so-called “biosimilar” drug clears the way for companies to make lower-cost versions of expensive biologic drugs, saving patients money and improving access to the medications.
from WebMD Health http://ift.tt/199Kta2
via IFTTT
from WebMD Health http://ift.tt/199Kta2
via IFTTT
No comments:
Post a Comment